Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-OPERA: Certolizumab Pegol in Early Rheumatoid Arthritis
NCT01451203Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2011
- Primary completion
- Aug 2013
- Modality
- Antibody Fragments, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of certolizumab pegol in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Oct 2011; status: completed.
02
Drugs
certolizumab pegol
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01451203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451203.